Author

Corbalan JJ

Albert Einstein College of Medicine, Department of Medicine (Cardiology) - Cited by 891 - Cardiovascular disease - Drug testing - Large animal models - Rodent Models - In vitro models

Biography

Dr. J. Jose Corbalan is an associate professor and scientist works in the Nanomedical Research Laboratories, Ohio University, Athens, OH 45701, USA. He also works at Albert Einstein College of Medicine, Department of Medicine (Cardiology).
Title
Cited by
Year
Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects
JJ Corbalan, C Medina, A Jacoby, T Malinski, MW RadomskiInternational journal of nanomedicine, 2821-2835, 2011201
128
2011
Mechanisms of toxicity of amorphous silica nanoparticles on human lung submucosal cells in vitro: protective effects of fisetin
J McCarthy, I Inkielewicz-Stepniak, JJ Corbalan, MW RadomskiChemical research in toxicology 25 (10), 2227-2235, 2012201
122
2012
Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis
JJ Corbalan, C Medina, A Jacoby, T Malinski, MW RadomskiInternational journal of nanomedicine, 631-639, 2012201
112
2012
Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats
RP Mason, RF Jacob, R Kubant, A Ciszewski, JJ Corbalan, T MalinskiJournal of cardiovascular pharmacology 60 (5), 467-473, 2012201
98
2012
Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK–MMP-9 pathway
A Radziwon-Balicka, MJ Santos-Martinez, JJ Corbalan, S O’Sullivan, ...Carcinogenesis 35 (2), 324-332, 2014201
96
2014
A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy
D Amgalan, TP Garner, R Pekson, XF Jia, M Yanamandala, V Paulino, ...Nature cancer 1 (3), 315-328, 2020202
72
2020
Pegylation increases platelet biocompatibility of gold nanoparticles
MJ Santos-Martinez, K Rahme, JJ Corbalan, C Faulkner, JD Holmes, ...Journal of biomedical nanotechnology 10 (6), 1004-1015, 2014201
68
2014
Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes
RP Mason, JJ Corbalan, RF Jacob, H Dawoud, T MalinskiJ Physiol Pharmacol 66 (1), 65-72, 2015201
48
2015
Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants
RP Mason, RF Jacob, R Kubant, A Jacoby, F Louka, JJ Corbalan, ...British journal of clinical pharmacology 74 (1), 141-146, 2012201
39
2012
Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes
RP Mason, RF Jacob, JJ Corbalan, R Kaliszan, T MalinskiAmerican journal of hypertension 27 (3), 482-488, 2014201
35
2014
The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells
RP Mason, RF Jacob, JJ Corbalan, D Szczesny, K Matysiak, T MalinskiBMC Pharmacology and Toxicology 14 (1), 1-9, 2013201
31
2013
RCAN1–calcineurin axis and the set-point for myocardial damage during ischemia-reperfusion
JJ Corbalan, RN KitsisCirculation research 122 (6), 796-798, 2018201
15
2018
Combination eicosapentaenoic acid and statin treatment reversed endothelial dysfunction in HUVECs exposed to oxidized LDL
RP Mason, RF Jacob, JJ Corbalan, T MalinskiJournal of Clinical Lipidology 8 (3), 342-343, 2014201
11
2014
Effects of dipeptidyl peptidase-4 inhibition on endothelial nitric oxide release, blood pressure and SICAM-1 levels in hypertensive rats
RP Mason, R Jacob, JJ Corbalan, R Kubant, A Ciszewski, T MalinskiJournal of the American College of Cardiology 59 (13S), E1543-E1543, 2012201
6
2012
Nanomedical Approach to Monitor the Central Role of NO/ONOOImbalance in Ischemic Stroke Brain Damage-The Effects of Statins and Heme Oxygenase-1
G Heeba, JJ Corbalan, S Patton, A Burewicz, AT Stys, T MalinskiJournal of Nanomedicine & Nanotechnology 5 (), 1, 20120
4
2014
Eicosapentaenoic acid reduces small dense low density lipoprotein oxidation and improves endothelial function in vitro as compared to other triglyceride-lowering agents
RP Mason, R Jacob, JJ Corbalan, T MalinskiJournal of the American College of Cardiology 65 (10S), A219-A219, 2015201
3
2015
Saxagliptin reduces lesion formation and reverses endothelial dysfunction in CETP-apob100 mice with atherosclerosis
Saxagliptin reduces lesion formation and reverses endothelial dysfunction in CETP-apob00 mice with atherosclerosisRP Mason, RF Jacob, JJ Corbalan, T MalinskiCirculation 28 (suppl_22), A58-A58, 20320
1
2013